ARCHIVES

FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication

This article is from The Cancer Letter archive.

Vol. 37 No. 43 | November 18, 2011

Download PDF Visit The Full Archive

Related Articles

DCT Bard Okays Concepts for BRMP Contract Programs

June 22, 1984

Local Labs Not As Accurate As Central Testing For HER2

August 30, 2002

Oxaliplatin Regimen May Beat Standard For Advanced Colorectal Cancer, NCI Says

April 26, 2002

“What Is Good For NCI Is Good For NIH,” Broder Says In Address

January 13, 1995

Patient Advocacy: Prostate Cancer Agenda Didn’t Include NCI Plans, Lausner Says

November 29, 1996

Panitumumab Improves PFS In Metastatic Colon Cancer

April 28, 2006